Blog

Facebook (NASDAQ: FB) and its subsidiary Oculus have been the talk of the VR industry for most of the past few years. But the reality is that it's far from the leader in VR headsets sold. That title

Lately, electric-car maker Tesla (NASDAQ: TSLA) has gone from a company known for missing important delivery and production targets to one that is easily meeting them. In 2019, for instance, total

Image source: The Motley Fool.

Great Western Bancorp (NYSE: GWB)Q1 2020 Earnings CallJan 28, 2020, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Acceleron Pharma (NASDAQ: XLRN) are up 41% at 11:19 a.m. EST following a report after the closing bell yesterday that the company's heart drug sotatercept was successful in a phase 2

The pending nuptials between Sprint (NYSE: S) and T-Mobile (NASDAQ: TMUS) are still waiting on regulators to offer their final blessings, and there are no assurances that vows will ultimately be

Shares of 3M (NYSE: MMM) fell more than 5% in early trading Tuesday after the conglomerate reported fourth-quarter earnings that fell short of expectations and full-year sales that were down year

The stock market managed to bounce back somewhat from the large drops in major benchmarks on Monday. Even though fears about the outbreak of coronavirus in the Wuhan area of China aren't diminishing

While Microsoft (NASDAQ: MSFT) is best known for its operating system and software products, the company's resurgence in recent years has been largely attributed to its successful foray into cloud

Shares of Harley-Davidson (NYSE: HOG), dropped 7% lower early Tuesday morning, before recovering some losses, as the markets digested the motorcycle maker's disappointing fourth-quarter results.

After a few quarters of producing big earnings results, Amazon (NASDAQ: AMZN) has returned to another phase of investing back into the company. Earnings fell 26% in the third quarter, coming in

Down 15% one day. Up 15% another. I'll give FuelCell Energy (NASDAQ: FCEL) this much: Investing in this stock is anything but boring!

Today, FuelCell stock is bouncing back from a 15% sell-off

The Food and Drug Administration (FDA) has accepted an application from Sanofi (NASDAQ: SNY) and Regeneron Pharmaceutical (NASDAQ: REGN) to review the drug Dupixent for use by children ages 6 to 11

When it comes to telecom stocks, Frontier Communications (NASDAQ: FTR) sports what looks like an attractive price. It's just $0.59 per share and hovering near a 52-week low compared to the $38.55 of

Shares of Novavax (NASDAQ: NVAX) were falling 12.7% lower as of 10:54 a.m. on Tuesday. There wasn't any real news driving Novavax's decline. Instead, investors appear to be taking profits off the

Within two weeks of each other in November of last year, two members of the next generation of on-demand streaming services made their big debuts. First came Apple's (NASDAQ: AAPL) Apple TV+, which

With phase one of the trade deal between the U.S. and China signed, some investors can breathe a sigh of relief. A little more stability was restored in the global economy now that China has agreed

If you are looking for exposure in the refining sector, Phillips 66 (NYSE: PSX) and Valero Energy (NYSE: VLO) are among the stocks that first come to the mind. Both are top refiners with some of the

E-commerce has experienced unprecedented growth over the last two decades. While much of that has occurred in developed markets with wide internet access, there is still a lot of untapped growth

The marijuana industry's recent oversupply problems have been well documented, and now, it seems that the hemp segment of the market is experiencing similar challenges.

A report published Monday by

Genetic medicines and cellular therapies have an enormous potential to treat, and possibly cure, currently untreatable diseases. Nonetheless, it's important for investors to remember that "simpler"

Longtime Garmin (NASDAQ: GRMN) shareholders may remember the roaring rally in late 2007, followed by the collapse along with the market during the Great Recession. Since then, the stock's upward

Everyone who follows Pfizer (NYSE: PFE) expected that 2019 would be a challenging year for the big drugmaker. And it was. The company's blockbuster nerve-pain drug Lyrica faced generic competition

Netflix (NASDAQ: NFLX) has bought its way into a leadership position in the content space. Unlike key rival Walt Disney (NYSE: DIS), which has been amassing its content library since 1937 when it

The oil and gas industry didn't have a great year in 2019, as crude oil prices dropped about 9% and natural gas prices dropped 18% amid a continued increase in supply. While that's good for

Nearly everyone wants to save as much as possible for retirement, but doing so is a lot easier said than done.

Only 28% of baby boomers think they're doing a good job of financially preparing for